Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effectiveness of the dual serotonin norepinephrine reuptake inhibitor venlafaxine in depressed patients

Trial Profile

Effectiveness of the dual serotonin norepinephrine reuptake inhibitor venlafaxine in depressed patients

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jun 2010

At a glance

  • Drugs Atomoxetine; Paroxetine; Venlafaxine
  • Indications Major depressive disorder
  • Focus Pharmacodynamics
  • Sponsors Wyeth
  • Most Recent Events

    • 10 Jun 2010 Results preseneted at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum
    • 05 Dec 2009 Status changed from not stated to completed.
    • 21 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top